003017 大洋生物
按盤價 
18.750 -0.110 (-0.583%)
18.750 -0.110 (-0.583%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.035 | 5.018 | 8.172 | 7.185 | 12.581 |
| 總資產報酬率 ROA (%) | 3.246 | 3.274 | 5.601 | 5.379 | 9.774 |
| 投入資產回報率 ROIC (%) | 3.593 | 3.700 | 6.241 | 5.907 | 11.011 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.049 | 18.084 | 13.822 | 19.428 | 24.426 |
| 營業利潤率 (%) | 8.098 | 6.122 | 5.594 | 10.128 | 14.994 |
| 息稅前利潤/營業總收入 (%) | 8.052 | 4.879 | 5.619 | 10.120 | 15.215 |
| 淨利潤/營業總收入 (%) | 7.631 | 5.439 | 7.629 | 8.939 | 13.505 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.918 | 95.717 | 61.628 | 67.878 | 81.520 |
| 價值變動淨收益/利潤總額(%) | -2.034 | 3.495 | 5.075 | 13.566 | 1.637 |
| 營業外收支淨額/利潤總額(%) | -0.411 | -19.804 | -3.028 | -4.186 | -1.447 | 償債能力分析 |
| 流動比率 (X) | 1.213 | 1.538 | 1.523 | 2.342 | 3.482 |
| 速動比率 (X) | 0.974 | 1.184 | 1.257 | 1.832 | 3.134 |
| 資產負債率 (%) | 36.240 | 34.814 | 34.681 | 27.914 | 0.220 |
| 帶息債務/全部投入資本 (%) | 28.149 | 23.805 | 22.474 | 19.168 | 12.007 |
| 股東權益/帶息債務 (%) | 246.952 | 308.124 | 329.963 | 410.636 | 717.650 |
| 股東權益/負債合計 (%) | 175.935 | 187.237 | 188.341 | 258.241 | 353.984 |
| 利息保障倍數 (X) | -665.110 | -21.119 | 29.751 | 25.395 | 34.993 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 22.029 | 21.031 | 17.565 | 14.914 | 15.143 |
| 存貨周轉天數 (天) | 70.392 | 66.702 | 56.946 | 66.017 | 53.449 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
